360Dx

Illumina to Launch New NovaSeq Chip, iSeq Kit; Grow Oncology and Reproductive Health Business

Jan 08, 2019

SAN FRANCISCO (GenomeWeb) – Illumina plans to launch a new chip for its NovaSeq instrument and upgrades to the iSeq sequencer in the first quarter of 2019, according to a presentation at the JP Morgan Healthcare Conference. Unlike in previous years, the company did not launch or preview a new sequencing instrument this time.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Illumina to Launch New NovaSeq Chip, iSeq Kit; Grow Oncology and Reproductive Health Business

To read the full story....

Breaking News

BARDA Awards $5.4M to Luminex for Expanded Respiratory Panel With Coronavirus Target

In Brief This Week: Thermo Fisher Scientific, Fluidigm, Veracyte, and More

Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test

BGI Genomics Gets CE Mark for Multiplexed SARS-CoV-2, Influenza Tests

Commercial Coronavirus Antibody Tests Show Wide Variation in Accuracy in New Study

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

The Promise of Liquid Biopsy for Cancer Diagnostics and Therapeutic Monitoring: Are We There Yet?

What's Popular?

Grail Deal Will Enable Illumina to Expand From Tech Innovator to Diagnostics Provider

UBS Downgrades Illumina to Neutral; Expresses Doubts About Grail Deal

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

Illumina to Acquire Grail for $8B in Cash and Stock

JP Morgan Downgrades Illumina to Neutral on Grail Deal

Sponsorships